Prohibited List
To consult the 2012 List, the 2012 Monitoring Program, a summary of modifications, a document providing additional information in regards to the reintroduction of pseudoephedrine, as well as a Q&A on major changes, click here.
To consult the 2012 List, the 2012 Monitoring Program, a summary of modifications, a document providing additional information in regards to the reintroduction of pseudoephedrine, as well as a Q&A on major changes, click here.